AdaptHealth (AHCO) EBIT Growth (1y) (2019 - 2026)
AdaptHealth (AHCO) EBIT Growth (1y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 90.95% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | -18.12% |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 74.18% |
| 10 | AdaptHealth | 1.50 Bn | 1.45 Bn | 111.50 Mn | -76.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76.31% |
| Dec 31, 2025 | -175.03% |
| Sep 30, 2025 | -2.77% |
| Jun 30, 2025 | 52.27% |
| Mar 31, 2025 | -54.15% |
| Dec 31, 2024 | 144.84% |
| Sep 30, 2024 | 113.77% |
| Jun 30, 2024 | -4.08% |
| Mar 31, 2024 | 93.04% |
| Dec 31, 2023 | -914.77% |
| Sep 30, 2023 | -970.72% |
| Jun 30, 2023 | -8.31% |
| Mar 31, 2023 | -49.22% |
| Dec 31, 2022 | -61.30% |
| Sep 30, 2022 | -30.06% |
| Jun 30, 2022 | -9.52% |
| Mar 31, 2022 | 234.56% |
| Dec 31, 2021 | 101.41% |
| Sep 30, 2021 | 471.01% |
| Jun 30, 2021 | 320.08% |